<DOC>
	<DOCNO>NCT01329666</DOCNO>
	<brief_summary>Primary hyperparathyroidism ( PHPT ) common disease occur 1 10,000 people every year . In presence condition , parathyroid gland produce excessive amount parathyroid hormone ( PTH ) , regulate calcium level . The high level parathyroid hormone remove much calcium bone , deposit excess calcium blood , filter urine kidney . Bone health threaten excess calcium loss weaken bone structure . Other affected organ include skeleton ( calcium loss lead `` weaken '' skeleton ) , kidney ( high blood calcium lead kidney stone ) . It evident majority patient even mild Primary Hyperparathyroidism vitamin D deficient . In 2009 , new international guideline management asymptomatic PHPT direct physician measure 25-hydroxyvitamin D ( D3 25-OHD ) patient , replete reserve vitamin D level low ( &lt; 20 ng/ml ) . However , recommendation vitamin D repletion give , limited data regard effect vitamin D repletion , appropriate dosing safety . Therefore , urgent need data upon base recommendation , well data effect treatment upon bone . Subjects low vitamin D3 level select trial . They give enough vitamin D3 raise low blood level low normal range . The assessment study , include quadruple label bone biopsy , allow u document short term effect administer vitamin D3 change bone . All participant enrol trial vitamin D3 deficient . Participants take antibiotic ( tetracycline ) 4 time day mark start point bone change assess . After 3 day tetracycline , 12 week course vitamin D3 placebo initiate . Six 7 participant receive study drug ( active vitamin D3 ) , 1 7 receive placebo ( sugar pill ) . Ten week later , another 3-day course tetracycline give . At end 12 week , bone biopsy do . A small piece bone ( size pencil eraser ) remove hip ( iliac crest ) . The bone analyze determine effect vitamin D3 primary hyperparathyroidism . There 4 study visit : Screening , Baseline , Week 8 , Week 12 bone biopsy perform . Study Procedures : Medical Social History Blood test ( drawn study center local Quest Lab ) 24-Hour urine collection calcium creatinine excretion Abdominal X-ray ( assess kidney stone ) Transiliac crest Bone Biopsy</brief_summary>
	<brief_title>Primary Hyperparathyroidism ( PHPT ) : Early Effect Vitamin D</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Females male &gt; = 45 year age 2 . PHPT , define elevate PTH elevate serum calcium 3 . Screening 25OHD &lt; = 20 ng/ml 1 . Premenopausal 2 . Serum calcium &gt; 11.5mg/dl . 3 . Urinary calcium &gt; 350 mg/dl . 4 . Active nephrolithiasis 5 . Nephocalcinosis 6 . Known sensitivity tetracycline ( Sumycin ) 7 . Familial history hyperparathyroid syndromes 8 . Bisphosphonate use within past 2 year . 9 . Current use Prolia . 10 . Current use Cinacalcet . 11 . Currently use Cimetidine . 12 . Currently use Colestipol . 13 . Currently use Orlistat . 14 . Current past malignancy , except cure basal squamous cell skin carcinoma cancer recur least five year . 15 . Current tuberculosis , history Sarcoidosis , HIV/AIDS , chronic kidney disease ( serum creatinine &gt; = 1.5 ) , liver disease , Crohn 's Disease , Celiac Disease , gastric bypass</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Primary Hyperparathyroidism</keyword>
	<keyword>Endocrinology</keyword>
	<keyword>Hypercalcemia</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Parathyroid Hormone</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Bone Density</keyword>
	<keyword>Vitamin D repletion</keyword>
	<keyword>Vitamin D Supplements</keyword>
</DOC>